Legal & General Group PLC Tarsus Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 31,311 shares of TARS stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,311

Previous 35,426 11.62%

Holding current value

$2.26 Million

Previous $1.44 Million 29.62%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$38.82 - $59.43 $159,744 - $244,554	-4,115 Reduced 11.62%	31,311 $1.86 Million
Q2 2025 Aug 12, 2025	BUY	$39.88 - $51.49 $312,340 - $403,269	7,832 Added 28.38%	35,426 $1.44 Million
Q1 2025 May 15, 2025	BUY	$41.29 - $56.94 $41,248 - $56,883	999 Added 3.76%	27,594 $1.42 Million
Q4 2024 Feb 13, 2025	SELL	$32.27 - $55.37 $18,071 - $31,007	-560 Reduced 2.06%	26,595 $1.47 Million
Q3 2024 Feb 28, 2025	SELL	$21.54 - $34.6 $43,424 - $69,753	-2,016 Reduced 7.58%	24,579 $808,000

Q3 2024 Nov 14, 2024	BUY	$21.54 - $34.6 $2,003 - $3,217	93 Added 0.34%	27,155 $893,000
Q2 2024 May 29, 2025	BUY	$25.17 - $38.73 $41,656 - $64,098	1,655 Added 7.25%	24,486 $665,000
Q2 2024 Aug 14, 2024	BUY	$25.17 - $38.73 $106,494 - $163,866	4,231 Added 18.53%	27,062 $735,000
Q1 2024 May 29, 2025	SELL	$19.61 - $39.22 $93,402 - $186,804	-4,763 Reduced 17.26%	22,831 $829,000
Q4 2023 May 29, 2025	SELL	$12.98 - $20.73 $61,823 - $98,736	-4,763 Reduced 17.26%	22,831 $462,000
Q4 2023 Feb 15, 2024	BUY	$12.98 - $20.73 $29,581 - $47,243	2,279 Added 11.09%	22,831 $462,000
Q3 2023 Nov 14, 2023	BUY	$14.75 - $24.62 $110,197 - $183,936	7,471 Added 57.11%	20,552 $365,000
Q2 2023 Aug 14, 2023	BUY	$11.57 - $19.63 $66,365 - $112,597	5,736 Added 78.09%	13,081 $236,000
Q1 2023 May 15, 2023	BUY	$11.92 - $16.27 $5,268 - $7,191	442 Added 6.4%	7,345 $92,000
Q4 2022 Feb 14, 2023	BUY	$14.12 - $18.72 $63,017 - $83,547	4,463 Added 182.91%	6,903 $101,000
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $12,798 - $16,816	909 Added 59.37%	2,440 $41,000
Q2 2022 Aug 22, 2022	BUY	$11.08 - $19.08 $7,346 - $12,650	663 Added 76.38%	1,531 $22,000
Q1 2022 May 16, 2022	BUY	$14.49 - $24.28 $724 - $1,214	50 Added 6.11%	868 $15,000
Q2 2021 Aug 12, 2021	BUY	$27.16 - $38.59 $4,861 - $6,907	179 Added 28.01%	818 $24,000
Q4 2020 Feb 12, 2021	BUY	$19.17 - $49.62 $12,249 - $31,707	639 New	639 $27,000

Others Institutions Holding TARS

# of Institutions

231

Shares Held

45M

Call Options Held

51.6K

Put Options Held

15.8K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.92B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Tarsus Pharmaceuticals, Inc. Transaction History